Nuron Biotech to Present at Biotechnology Industry Organization (BIO) Business Forum®
4/22/2013 9:25:03 AM
More...
|
Nuron Biotech Selected to Present at Future Leaders in the Biotech Industry Conference
4/2/2013 10:39:22 AM
More...
|
Nuron Biotech Receives Pennsylvania Bio's 2013 Deal of the Year Award for Advancing Bioscience Industry
3/18/2013 10:04:27 AM
More...
|
Nuron Biotech Raises $80 Million
12/20/2012 6:38:23 AM
More...
|
Nuron Biotech Buys Pfizer Inc. (PFE)'s Preventive Vaccine Meningitec
12/10/2012 7:53:20 AM
More...
|
Nuron Biotech Completes Enrollment of a Pivotal Phase 3 Study for Proprietary Recombinant Human Interferon Beta-1b (NU100) in Relapsing Remitting Multiple Sclerosis
11/13/2012 9:29:15 AM
More...
|
Nuron Biotech Expands Portfolio With Exclusive, Worldwide License for an Amyloid Beta 42 DNA Vaccine Candidate for Alzheimer's Disease
4/9/2012 7:59:58 AM
More...
|
Nuron Biotech Expands Portfolio With License of Therapeutic and Prophylactic Hepatitis Vaccine Candidates
3/5/2012 11:59:25 AM
More...
|
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
1/13/2012 6:30:43 AM
More...
|
Nuron Biotech Exercises Option for a Licence to PolyTherics' TheraPEG™ Technology to Develop a Long-Acting Human Interferon beta-1b
12/13/2011 9:28:11 AM
More...
|
|